Stakk Ltd has secured a significant U.S. healthcare technology contract, pushing its annualised revenue run rate to approximately A$26 million. The deal highlights accelerating adoption of its AI-native Digital Trust platform across regulated industries.
- New U.S. healthcare client adds A$3.85 million annualised revenue
- Annualised revenue run rate surges 2,067% since December 2024
- Two-year contract with quarterly payments starting before June 30, 2026
- Deployment targets healthcare identity and credential validation workflows
- Expands Stakk’s AI-native Digital Trust infrastructure footprint
New US Healthcare Contract Elevates Revenue Run Rate
Stakk Ltd (ASX:SKK) has landed a new U.S. healthcare technology client expected to contribute approximately A$3.85 million (US$2.75 million) in annualised revenue. This latest contract lifts Stakk’s annualised revenue run rate dramatically to around A$26 million, marking a 2,067% increase from about A$1.2 million in December 2024. The deal was formalised between May 29 and June 1, 2026, with an initial two-year term and quarterly payments in advance.
Tailored AI-Driven Trust Solutions for Healthcare
The agreement involves deploying Stakk’s AI-native Digital Trust infrastructure to validate and match digital credentials with the presenting individual across healthcare-related services. The platform integrates real-time identity validation, document authenticity checks, federated signal intelligence, and deterministic decisioning to ensure secure, authenticated access. This deployment reinforces Stakk’s strategy of delivering a unified trust and decisioning layer across regulated sectors, including financial services, telecommunications, healthcare, and government.
Rapid Enterprise Adoption Fuels Growth Trajectory
Since acquiring Radical DBX, Inc., Stakk’s annualised revenue run rate has surged from approximately A$1.2 million to A$26 million, reflecting accelerating enterprise uptake. The company points to growing demand for consolidated, real-time Digital Trust infrastructure capable of addressing synthetic identities, manipulated digital signals, account takeover risks, and autonomous decisioning; challenges that legacy SaaS systems struggle to manage effectively.
Contract Details and Financial Implications
The new client, a privately held health technology platform based in New York, remains confidential due to commercial sensitivity. The contract is structured as a fixed-term platform licensing arrangement combined with customised workflow and data intelligence model delivery. Stakk expects to receive the first quarterly payment before June 30, 2026, which will be reflected in its FY26 fourth-quarter cash position. While the annualised revenue run rate offers a snapshot of scale, actual booked revenue for the 12 months ending June 30, 2026, will be lower due to phased contract commencements and implementations.
Expanding Footprint in Regulated Industries
Stakk’s platform now serves over 215 regulated institutions, including banks, fintechs, and enterprises, governing high-stakes digital interactions in real time. This latest contract win underscores the company’s growing footprint in the U.S. healthcare sector, a market where secure credential validation and trust infrastructure are increasingly critical. The deal also highlights the broader shift towards AI-native trust solutions replacing fragmented legacy systems in regulated environments.
Bottom Line?
Stakk’s rapid revenue run rate growth and healthcare sector expansion signal strong market traction, but actual cash flow timing and contract execution remain key near-term indicators.
Questions in the middle?
- How will Stakk manage deployment timelines to convert annualised revenue into booked revenue?
- What are the implications of expanding into healthcare for Stakk’s regulatory compliance and operational complexity?
- Can Stakk sustain this growth momentum across other regulated industries beyond healthcare?